83 related articles for article (PubMed ID: 27662009)
1. Innate lymphoid cells are expanded and functionally altered in chronic lymphocytic leukemia.
de Weerdt I; van Hoeven V; Munneke JM; Endstra S; Hofland T; Hazenberg MD; Kater AP
Haematologica; 2016 Nov; 101(11):e461-e464. PubMed ID: 27662009
[No Abstract] [Full Text] [Related]
2. Erythrophagocytosis by lymphocytes in chronic lymphocytic leukemia.
Wang S; Bo J
Int J Lab Hematol; 2024 Jun; 46(3):421-422. PubMed ID: 37855188
[No Abstract] [Full Text] [Related]
3. Prostaglandin D2 regulates human type 2 innate lymphoid cell chemotaxis.
Chang JE; Doherty TA; Baum R; Broide D
J Allergy Clin Immunol; 2014 Mar; 133(3):899-901.e3. PubMed ID: 24210841
[No Abstract] [Full Text] [Related]
4. Innate lymphoid cells: a paradigm for low SSI in cleft lip repair.
Simmerman E; Qin X; Marshall B; Perry L; Cai L; Wang T; Yu J; Akbari O; Baban B
J Surg Res; 2016 Oct; 205(2):312-317. PubMed ID: 27664878
[TBL] [Abstract][Full Text] [Related]
5. Deciphering the Innate Lymphoid Cell Transcriptional Program.
Seillet C; Mielke LA; Amann-Zalcenstein DB; Su S; Gao J; Almeida FF; Shi W; Ritchie ME; Naik SH; Huntington ND; Carotta S; Belz GT
Cell Rep; 2016 Oct; 17(2):436-447. PubMed ID: 27705792
[TBL] [Abstract][Full Text] [Related]
6. Differential expression, localization and activity of MARCKS between mantle cell lymphoma and chronic lymphocytic leukemia.
Vargova J; Vargova K; Dusilkova N; Kulvait V; Pospisil V; Zavadil J; Trneny M; Klener P; Stopka T
Blood Cancer J; 2016 Sep; 6(9):e475. PubMed ID: 27662204
[No Abstract] [Full Text] [Related]
7. Human innate lymphoid cells.
Mjösberg J; Spits H
J Allergy Clin Immunol; 2016 Nov; 138(5):1265-1276. PubMed ID: 27677386
[TBL] [Abstract][Full Text] [Related]
8. A tissue checkpoint regulates type 2 immunity.
Van Dyken SJ; Nussbaum JC; Lee J; Molofsky AB; Liang HE; Pollack JL; Gate RE; Haliburton GE; Ye CJ; Marson A; Erle DJ; Locksley RM
Nat Immunol; 2016 Dec; 17(12):1381-1387. PubMed ID: 27749840
[TBL] [Abstract][Full Text] [Related]
9. Type 2 innate lymphoid cell suppression by regulatory T cells attenuates airway hyperreactivity and requires inducible T-cell costimulator-inducible T-cell costimulator ligand interaction.
Rigas D; Lewis G; Aron JL; Wang B; Banie H; Sankaranarayanan I; Galle-Treger L; Maazi H; Lo R; Freeman GJ; Sharpe AH; Soroosh P; Akbari O
J Allergy Clin Immunol; 2017 May; 139(5):1468-1477.e2. PubMed ID: 27717665
[TBL] [Abstract][Full Text] [Related]
10. Depletion of major pathogenic cells in asthma by targeting CRTh2.
Huang T; Hazen M; Shang Y; Zhou M; Wu X; Yan D; Lin Z; Solon M; Luis E; Ngu H; Shi Y; Katewa A; Choy DF; Ramamoorthi N; Castellanos ER; Balazs M; Xu M; Lee WP; Matsumoto ML; Payandeh J; Arron JR; Hongo JA; Wang J; Hötzel I; Austin CD; Reif K
JCI Insight; 2016 May; 1(7):e86689. PubMed ID: 27699264
[TBL] [Abstract][Full Text] [Related]
11. B cells and macrophages pursue a common path toward the development and progression of chronic lymphocytic leukemia.
Galletti G; Caligaris-Cappio F; Bertilaccio MT
Leukemia; 2016 Dec; 30(12):2293-2301. PubMed ID: 27677742
[TBL] [Abstract][Full Text] [Related]
12. Targeting BTK through microRNA in chronic lymphocytic leukemia.
Bottoni A; Rizzotto L; Lai TH; Liu C; Smith LL; Mantel R; Reiff S; El-Gamal D; Larkin K; Johnson AJ; Lapalombella R; Lehman A; Plunkett W; Byrd JC; Blachly JS; Woyach JA; Sampath D
Blood; 2016 Dec; 128(26):3101-3112. PubMed ID: 27756747
[TBL] [Abstract][Full Text] [Related]
13. Elevated IL-17A and IL-22 regulate expression of inducible CD38 and Zap-70 in chronic lymphocytic leukemia.
Kouzegaran S; Siroosbakht S; Farsad BF; Rezakhaniha B; Dormanesh B; Behnod V; Tanha AS
Cytometry B Clin Cytom; 2018 Jan; 94(1):143-147. PubMed ID: 27718514
[TBL] [Abstract][Full Text] [Related]
14. T-bet inhibits innate lymphoid cell-mediated eosinophilic airway inflammation by suppressing IL-9 production.
Matsuki A; Takatori H; Makita S; Yokota M; Tamachi T; Suto A; Suzuki K; Hirose K; Nakajima H
J Allergy Clin Immunol; 2017 Apr; 139(4):1355-1367.e6. PubMed ID: 27670243
[TBL] [Abstract][Full Text] [Related]
15. Twenty-One Flavors of Type 1 Innate Lymphoid Cells with PD-1 (Programmed Cell Death-1 Receptor) Sprinkles.
Smith KJ; Sciumè G; Amarnath S
Discov Immunol; 2023; 2(1):kyad003. PubMed ID: 38567059
[TBL] [Abstract][Full Text] [Related]
16. Immunometabolic reprogramming, another cancer hallmark.
Kumar V; Stewart JH
Front Immunol; 2023; 14():1125874. PubMed ID: 37275901
[TBL] [Abstract][Full Text] [Related]
17. An updated perspective on immunoglobulin replacement in chronic lymphocytic leukaemia in the era of targeted therapies.
Khan S; Allsup D; Molica S
Front Oncol; 2023; 13():1135812. PubMed ID: 37091176
[TBL] [Abstract][Full Text] [Related]
18. IL-18 and VEGF-A trigger type 2 innate lymphoid cell accumulation and pro-tumoral function in chronic myeloid leukemia.
Fiordi B; Salvestrini V; Gugliotta G; Castagnetti F; Curti A; Speiser DE; Marcenaro E; Jandus C; Trabanelli S
Haematologica; 2023 Sep; 108(9):2396-2409. PubMed ID: 37021528
[TBL] [Abstract][Full Text] [Related]
19. Innate lymphoid cell (ILC) subsets are enriched in the skin of patients with hidradenitis suppurativa.
Petrasca A; Hambly R; Molloy O; Kearns S; Moran B; Smith CM; Hughes R; O'Donnell M; Zaborowski A; Winter D; Fletcher JM; Kirby B; Malara A
PLoS One; 2023; 18(2):e0281688. PubMed ID: 36780439
[TBL] [Abstract][Full Text] [Related]
20. Natural Killer Cells in Chronic Lymphocytic Leukemia: Functional Impairment and Therapeutic Potential.
Yano M; Byrd JC; Muthusamy N
Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
